Clinical Trials Browser

Phase 1/2 × INDUSTRY × Uterine Cervical Dysplasia × Clear all

NCT05496231 2025-02-03

A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age

Phase 1/2 Completed

1,080 enrolled 28 charts

Uterine Cervical Dysplasia, Infections

NCT02195089 2016-04-19

Efficacy and Safety Study of BLS_ILB_E710c for the Fertile Women With Cervical Intraepithelial Neoplasia(CIN3)

Phase 1/2 Completed

Uterine Cervical Dysplasia